PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TALK vs. LTRN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TALK and LTRN is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

TALK vs. LTRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Talkspace, Inc. (TALK) and Lantern Pharma Inc. (LTRN). The values are adjusted to include any dividend payments, if applicable.

-75.00%-70.00%-65.00%-60.00%-55.00%NovemberDecember2025FebruaryMarchApril
-73.96%
-75.53%
TALK
LTRN

Key characteristics

Sharpe Ratio

TALK:

-0.45

LTRN:

-0.74

Sortino Ratio

TALK:

-0.32

LTRN:

-1.14

Omega Ratio

TALK:

0.96

LTRN:

0.88

Calmar Ratio

TALK:

-0.32

LTRN:

-0.76

Martin Ratio

TALK:

-0.85

LTRN:

-1.42

Ulcer Index

TALK:

32.62%

LTRN:

46.17%

Daily Std Dev

TALK:

61.60%

LTRN:

88.49%

Max Drawdown

TALK:

-95.17%

LTRN:

-88.69%

Current Drawdown

TALK:

-78.26%

LTRN:

-86.36%

Fundamentals

Market Cap

TALK:

$442.99M

LTRN:

$32.25M

EPS

TALK:

$0.01

LTRN:

-$1.93

Total Revenue (TTM)

TALK:

$142.18M

LTRN:

$0.00

Gross Profit (TTM)

TALK:

$64.11M

LTRN:

-$46.27K

EBITDA (TTM)

TALK:

-$2.82M

LTRN:

-$16.48M

Returns By Period

In the year-to-date period, TALK achieves a -14.89% return, which is significantly lower than LTRN's -6.27% return.


TALK

YTD

-14.89%

1M

-4.71%

6M

6.48%

1Y

-27.55%

5Y*

N/A

10Y*

N/A

LTRN

YTD

-6.27%

1M

-23.14%

6M

-20.69%

1Y

-58.59%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TALK vs. LTRN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TALK
The Risk-Adjusted Performance Rank of TALK is 3434
Overall Rank
The Sharpe Ratio Rank of TALK is 3131
Sharpe Ratio Rank
The Sortino Ratio Rank of TALK is 3333
Sortino Ratio Rank
The Omega Ratio Rank of TALK is 3434
Omega Ratio Rank
The Calmar Ratio Rank of TALK is 3636
Calmar Ratio Rank
The Martin Ratio Rank of TALK is 3838
Martin Ratio Rank

LTRN
The Risk-Adjusted Performance Rank of LTRN is 1515
Overall Rank
The Sharpe Ratio Rank of LTRN is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of LTRN is 1414
Sortino Ratio Rank
The Omega Ratio Rank of LTRN is 1818
Omega Ratio Rank
The Calmar Ratio Rank of LTRN is 1010
Calmar Ratio Rank
The Martin Ratio Rank of LTRN is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TALK vs. LTRN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Talkspace, Inc. (TALK) and Lantern Pharma Inc. (LTRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TALK, currently valued at -0.45, compared to the broader market-2.00-1.000.001.002.00
TALK: -0.45
LTRN: -0.74
The chart of Sortino ratio for TALK, currently valued at -0.32, compared to the broader market-6.00-4.00-2.000.002.004.00
TALK: -0.32
LTRN: -1.14
The chart of Omega ratio for TALK, currently valued at 0.96, compared to the broader market0.501.001.502.00
TALK: 0.96
LTRN: 0.88
The chart of Calmar ratio for TALK, currently valued at -0.32, compared to the broader market0.001.002.003.004.00
TALK: -0.32
LTRN: -0.76
The chart of Martin ratio for TALK, currently valued at -0.85, compared to the broader market-10.000.0010.0020.00
TALK: -0.85
LTRN: -1.42

The current TALK Sharpe Ratio is -0.45, which is higher than the LTRN Sharpe Ratio of -0.74. The chart below compares the historical Sharpe Ratios of TALK and LTRN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
-0.45
-0.74
TALK
LTRN

Dividends

TALK vs. LTRN - Dividend Comparison

Neither TALK nor LTRN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

TALK vs. LTRN - Drawdown Comparison

The maximum TALK drawdown since its inception was -95.17%, which is greater than LTRN's maximum drawdown of -88.69%. Use the drawdown chart below to compare losses from any high point for TALK and LTRN. For additional features, visit the drawdowns tool.


-85.00%-80.00%-75.00%-70.00%-65.00%NovemberDecember2025FebruaryMarchApril
-78.26%
-86.36%
TALK
LTRN

Volatility

TALK vs. LTRN - Volatility Comparison

The current volatility for Talkspace, Inc. (TALK) is 14.58%, while Lantern Pharma Inc. (LTRN) has a volatility of 19.08%. This indicates that TALK experiences smaller price fluctuations and is considered to be less risky than LTRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%40.00%45.00%NovemberDecember2025FebruaryMarchApril
14.58%
19.08%
TALK
LTRN

Financials

TALK vs. LTRN - Financials Comparison

This section allows you to compare key financial metrics between Talkspace, Inc. and Lantern Pharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab